EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Could MMP3 and MMP9 Serve as Biomarkers in EBV-Related Oropharyngeal Cancer

Anna Polz, Kamal Morshed iD, Bartłomiej Drop, Małgorzata Polz-Dacewicz iD

International Journal of Molecular Sciences · 2024

DOI: 10.3390/ijms25052561 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2024. Verfasst von Anna Polz und 3 weiteren Autor:innen. Beteiligte Einrichtung: Genomed S.A., 02-971 Warsaw, Poland. Hauptthemen laut MEDLINE: Epstein-Barr Virus Infections, Carcinoma, Squamous Cell, Head and Neck Neoplasms, Oropharyngeal Neoplasms. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 61 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Medical University of Lublin.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The high incidence of, and mortality from, head and neck cancers (HNCs), including those related to Epstein–Barr virus (EBV), constitute a major challenge for modern medicine, both in terms of diagnosis and treatment. Therefore, many researchers have made efforts to identify diagnostic and prognostic factors. The aim of this study was to evaluate the diagnostic usefulness of matrix metalloproteinase 3 (MMP 3) and matrix metalloproteinase 9 (MMP 9) in EBV positive oropharyngeal squamous cell carcinoma (OPSCC) patients. For this purpose, the level of these MMPs in the serum of patients with EBV-positive OPSCC was analyzed in relation to the degree of histological differentiation and TNM classification. Our research team’s results indicate that the level of both MMPs is much higher in the EBV positive OPSCC patients compared to the EBV negative and control groups. Moreover, their levels were higher in more advanced clinical stages. Considering the possible correlation between the level of MMP 3, MMP 9 and anti-EBV antibodies, and also viral load, after statistical analysis using multiple linear regression, their high correlation was demonstrated. The obtained results confirm the diagnostic accuracy for MMP 3 and MMP 9. Both MMPs may be useful in the diagnosis of EBV positive OPSCC patients.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Epstein-Barr Virus InfectionsCarcinoma, Squamous CellHead and Neck NeoplasmsOropharyngeal NeoplasmsHumansHerpesvirus 4, HumanMatrix Metalloproteinase 3Matrix Metalloproteinase 9Squamous Cell Carcinoma of Head and NeckBiomarkers

Stichwörter der Autor:innen

EBVMMP 9MMP3biomarkersoropharyngeal cancer

Substanzen

Matrix Metalloproteinase 3Matrix Metalloproteinase 9BiomarkersMMP3 protein, humanMMP9 protein, human

Autor:innen und Institutionen

  • Genomed S.A., 02-971 Warsaw, Poland.
  • Department of Otolaryngology Head and Neck Cancer, University of Technology and Humanities in Radom, 26-600 Radom, Poland.
  • Department of Computer Science and Medical Statistics with e-health Laboratory, Medical University of Lublin, 20-090 Lublin, Poland.
  • Department of Virology with Viral Diagnostics Laboratory, Medical University of Lublin, 20-093 Lublin, Poland.

ORCID-Profile: Kamal Morshed, Małgorzata Polz-Dacewicz

Förderung

  • Medical University of Lublin

Zitieren

APA

Polz, A., Morshed, K., Drop, B., & Polz-Dacewicz, M. (2024). Could MMP3 and MMP9 Serve as Biomarkers in EBV-Related Oropharyngeal Cancer. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms25052561

Vancouver

Polz A, Morshed K, Drop B, Polz-Dacewicz M. Could MMP3 and MMP9 Serve as Biomarkers in EBV-Related Oropharyngeal Cancer. International Journal of Molecular Sciences. 2024. doi:10.3390/ijms25052561

BibTeX
@article{Polz2024,
  author = {Polz, Anna and Morshed, Kamal and Drop, Bartłomiej and Polz-Dacewicz, Małgorzata},
  title = {Could MMP3 and MMP9 Serve as Biomarkers in EBV-Related Oropharyngeal Cancer},
  journal = {International Journal of Molecular Sciences},
  year = {2024},
  doi = {10.3390/ijms25052561}
}
Kostenlos starten →